Zentalis Pharmaceuticals Announces Key Management Appointments [Yahoo! Finance]
Zentalis Pharmaceuticals, Inc. - common stock (ZNTL)
Company Research
Source: Yahoo! Finance
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced the appointment of Wendy Chang as Chief People Officer and Haibo Wang as Chief Business Officer. "Zentalis is sharply focused on our goal of bringing azenosertib to patients with gynecological malignancies,” said Julie Eastland, Chief Executive Officer. “To support this goal, we are continuing to tune our leadership team and today announced the appointment of two talented leaders with a strong track record of successfully supporting organizations through transitional periods. I look forward to working with Wendy, Haibo, and the rest of the leadership team as we advance the development of azenosertib.” Executive Biographies Wendy Chang, Chief People Officer Wendy is the Chief People Officer of
Show less
Read more
Impact Snapshot
Event Time:
ZNTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZNTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZNTL alerts
High impacting Zentalis Pharmaceuticals, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
ZNTL
News
- Zentalis Pharmaceuticals Announces Key Management AppointmentsGlobeNewswire
- Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law FirmPR Newswire
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law FirmGlobeNewswire
- Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors [Yahoo! Finance]Yahoo! Finance
ZNTL
Earnings
- 11/12/24 - Beat
ZNTL
Sec Filings
- 12/19/24 - Form 8-K/A
- 12/10/24 - Form SCHEDULE
- 12/6/24 - Form SCHEDULE
- ZNTL's page on the SEC website